Clinical Trial

Esketamine Combined With Remimazolam on Postoperative Sleep Disturbance and Anxiety in Patients

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 4, 2024 (before its estimated November 30, 2024 completion). Its status may not reflect the trial's current state.
Summary
To explore the effects of esketamine combined with remimazolam on postoperative sleep disturbance and anxiety in surgical patients undergoing gastroenteroscopies
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-10-25; most recent amendment 2024-09-01.
Status change: Not Yet Recruiting → Recruiting 2024-01-17
Trial Details
NCT Number NCT06108830
Lead Sponsor Tianjin Medical University General Hospital
Conditions Sleep Disturbance
Enrollment 400 participants
Start Date 2023-12-01
Primary Completion 2024-11-30 (estimated)
Study Completion 2024-12-10 (estimated)
Updated on ClinicalTrials.gov 2024-09-04